PL-02 from ICTHIC on VIMEO

Cancer associated thrombosis: risk factors and outcomes
S Eichinger (Austria)

PL-03 from ICTHIC on VIMEO

Update of incidental VTE in cancer
H Liebman (USA)

PL-04 from ICTHIC on VIMEO

Thrombosis and anticancer therapies: the contribution of chemotherapy and the specific drugs implicated in CAT
P Mismetti (France)

PL-05 from ICTHIC on VIMEO

Microparticles and cancer thrombosis in animal models
C Dubois (France)

PL-06 from ICTHIC on VIMEO

Inhibition of platelet function as a target for cancer progression control
BH Felding (USA)

PL-07 from ICTHIC on VIMEO

Biological basis of personalised anticoagulation in cancer: oncomir networks as regulators of coagulopathy
J Rak (Canada)

PL-08 from ICTHIC on VIMEO

Heparanase procoagulant activity in cancer progression
Y Nadir (Israel)

PL-09 from ICTHIC on VIMEO

Cancer-associated thrombosis novel biomarker discovery
N Kuderer (USA)

PL-10 from ICTHIC on VIMEO

VTE risk assessment models in cancer
I Pabinger (Austria)

PL-11 from ICTHIC on VIMEO

Polymorphisms of clotting factors and cancer risk
PM Sandset (Norway)

PL-12 from ICTHIC on VIMEO

Hypercoagulation markers in early diagnosis and prognosis in cancer: The HYPERCAN prospective study
A Falanga (Italy)

4thSKML from ICTHIC on Vimeo

FR Rickles (USA), W Ruf (USA, Germany)